Articles from Ronovo Surgical

Ronovo Surgical, a global innovator in next-generation surgical robotics, announced today the successful closing of its Series D financing, led by Johnson & Johnson’s corporate venture capital organization, JJDC, and participation from Lilly Asia Ventures, INCE Capital and Granite Asia, with a total investment of USD 67 million.

Recently, Ronovo Surgical invited top gynecology and urology surgeons to evaluate the performance of its newly unveiled Carina™ RAS Platform, the first modular robotic-assisted surgery (RAS) platform developed in China for laparoscopic procedures.

One of the fastest growing companies in the global robotic and digital surgery space, Ronovo Surgical recently announced successful closing of new financing to accelerate its vision of broad, cross-specialty adoption of robotic-assisted surgery (RAS). The latest round of financing arms Ronovo with more than $50M raised since 2020. Led by LongRiver Investments (LRI), this round garnered continued support from existing investors – Lilly Asia Ventures, Vivo Capital, Matrix Partners China and GGV Capital – with CEC Capital acting as exclusive financial advisor.

Ronovo Surgical, an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery to address the tremendous needs of the Chinese surgical market, recently announced successful closing of Series A financing.